New treatment strategy aims to stop rare liver cancer
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
Nine drug companies and six universities have now joined an unusual collaboration to break the logjam in research on acute myeloid leukemia (AML), a blood cancer lacking effective treatments....